Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
What To Know About The Republican National Convention: Trump Will Pick A Running Mate, MTG Will Speak—Melania Won’tWeight loss and diabetes may just be the beginning for drugs like Ozempic , Wegovy, Mounjaro and Zepbound as reports increasingly suggest they may have far-reaching benefits for treating conditions as diverse asNovo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound — brand names for drugs semaglutide and tirzepatide — are far and away the most famous members of a...
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to 335-0739 or sign upOur community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.
Glp-1 Mounjaro Weight Loss Sleep Apnea FDA Label Mental Health Parkinson's Alzheimer's
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Global alert issued over fake-Ozempic drugsThe World Health Organization says fake drugs, used for type-2 diabetes and weight loss, are a danger to health.
Read more »
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »
Next Gen Weight Loss Drugs Are Coming for Ozempic’s ThroneDozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.
Read more »
Non-Diabetic Use Of GLP-1 Drugs Like Ozempic For Weight Loss Affecting Retail Sizing CurvesI've been a journalist for 30 years, as a senior editor at W magazine, and for the last 17 years, covering retail and real estate as a senior editor at WWD. I write about luxury boutiques, independent retailers, department stores, mass chains, and digitally native brands, and the force that's redefining the way we shop – Amazon.
Read more »
‘Ozempic babies’: Popular diabetes drugs linked to surprise pregnanciesScientists believe that we are 'in a data-free zone' with respect to fertility and GLP-1 agonists like Ozempic and Wegovy.
Read more »
Hefty pets may benefit from Ozempic-style drugs, experts sayWatch out, Garfield. Ozempic, the wonder drug helping people shed troves of excess weight, may soon have counterparts for chunky cats and dogs as pharmaceutical companies are racing to develop a pr…
Read more »